The Portuguese Society of Rheumatology position paper on the use of biosimilars - 2017 update

The Portuguese Society of Rheumatology position paper on the use of biosimilars - 2017 update

Biosimilars are new and more affordable similar versions of previously approved reference biological drugs. Following the approval of the first monoclonal antibody biosimilar in 2013, the Portuguese Society of Rheumatology issued a position paper on the use of biosimilars in rheumatic conditions cov...

Full description

Bibliographic Details
Main Authors: Filipe C. Araújo, Alexandre Sepriano, Filipa Teixeira, Diogo Jesus, Teresa Martins Rocha, Patrícia Martins, Catarina Tenazinha, Ana Cordeiro, Ana Filipa Mourão, Cândida Silva, Carlos Vaz, Cátia Duarte, Cristina Ponte, Fernando Pimentel dos Santos, Helena Canhão, Helena Santos, José Bravo Pimentão, José Canas da Silva, Joaquim Pereira, José António Pereira da Silva, Luís Cunha Miranda, Margarida Oliveira, Maria João Saavedra, Pedro Gonçalves, Sandra Falcão, Susana Capela, João Eurico Fonseca
Format: Article
Language:English
Published: Sociedade Portuguesa de Reumatologia 2017-07-01
Series:Acta Reumatológica Portuguesa
Subjects:
rheumatoid arthritis
biosimilar
anti-tumor necrosis factor-alpha therapy
ankylosing spondylitis
Online Access:http://www.actareumatologica.com/files/article/1180_the_portuguese_society_of_rheumatology_position_paper_on_the_use_of_biosimilars_2017_update_file.pdf

Internet

http://www.actareumatologica.com/files/article/1180_the_portuguese_society_of_rheumatology_position_paper_on_the_use_of_biosimilars_2017_update_file.pdf

Similar Items